Mesencure—an enhanced cell therapy explicitly developed for treating acute respiratory distress in covid-19: from benchtop to bedside

por Bronshtein, T., Ben David, D., Novak, A., Kivity, V., Hamoud, S., Hayek, T., Meretzki, S.
Publicado 2021

Mesenchymal Stem/Stromal Cells: MESENCURE: A PROFESSIONALIZED CELL THERAPY FOR ARDS REDUCED THE MORTALITY OF SEVERE COVID-19 PATIENTS BY 68% ACCORDING TO A RECENTLY CONCLUDED MULTI...

por Bronshtein, T., David, D. Ben, Novak, A., Kivity, V., Hayek, T., Rozen, N., Meretzki, S., Hamoud, S.
Publicado 2022

Possible Divergent Local and Peripheral Immunological Effects of Low-Dose Mesencure, an Enhanced Mesenchymal Cell Therapy, May Contribute to Its Success in Treating Severe Covid-19...

por Bronshtein, Tomer, Ben David, Dror, Novak, Atara, Kivity, Vered, Meretzki, Shai, Hayek, Tony, Hamoud, Shadi, Rozen, Nimrod
Publicado 2021

Adipose-derived endothelial and mesenchymal stem cells enhance vascular network formation on three-dimensional constructs in vitro

por Freiman, Alina, Shandalov, Yulia, Rozenfeld, Dekel, Shor, Erez, Segal, Sofia, Ben-David, Dror, Meretzki, Shai, Egozi, Dana, Levenberg, Shulamit
Publicado 2016

Autologous cell-coated particles for the treatment of segmental bone defects—a new cell therapy approach

por Ben-David, Dror, Fishman, Bettina, Rubin, Guy, Novak, Atara, Laevsky, Ilana, Kadouri, Avinoam, Nishri Katz, Yasmin, Burger, Ora, Zaretsky, Asaph, Bor, Noam, Tzur, Ephraim, Meretzki, Shai, Rozen, Nimrod
Publicado 2019